OptimizeRxOPRX +3.84%54 FCF Margin % is -2.46% as of Mar. 2026. GuruFocus rates OPRX with a GF Score™ of 54/100 and a GF Value™ of $12.99 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, OptimizeRx ranks better than 81.61% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. OptimizeRx's Free Cash Flow for the
three
months ended in Mar. 2026 was $-0.5 Mil. OptimizeRx's Revenue for the
three
months ended in Mar. 2026 was $19.8 Mil. Therefore, OptimizeRx's FCF Margin % for the quarter that ended in Mar. 2026 was -2.46%.
The historical rank and industry rank for OptimizeRx's FCF Margin % or its related term are showing as below:
OPRX'
s FCF Margin % Range Over the Past 10 Years
Min: -14.86 Med: -5.07 Max: 17.1
Current: 13.33
During the past 13 years, the highest FCF Margin % of OptimizeRx was 17.10%. The lowest was -14.86%. And the median was -5.07%.
OPRX's FCF Margin % is ranked better than 81.61% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.34
vs OPRX: 13.33
OptimizeRx FCF Margin % Related Terms
OptimizeRx FCF Margin % Historical Data
* Premium members only.
The historical data trend for OptimizeRx's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, OptimizeRx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OptimizeRx FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, OptimizeRx's FCF Margin % distribution charts can be found below:
* The bar in red indicates where OptimizeRx's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OptimizeRx (OPRX) has a FCF Margin % of -2.46% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OptimizeRx and its competitors. According to the industry distribution chart, OptimizeRx ranks #123 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 18.4%.
Is OptimizeRx's FCF Margin % too high?
OptimizeRx's current FCF Margin % is -2.46%. Based on the distribution chart, OptimizeRx ranks #123 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, OptimizeRx has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OptimizeRx's FCF Margin % compare to DH and CCLD?
According to the Healthcare Providers & Services industry distribution chart, OptimizeRx ranks #123 out of 669 companies for FCF Margin %. This places OptimizeRx in the top 18% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.34, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OptimizeRx and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OptimizeRx's current FCF Margin % is -2.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptimizeRx stock overvalued right now?
Based on GuruFocus' analysis, OptimizeRx (OPRX) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.99, compared to a current price of $4.74 — trading 63.5% below its estimated fair value. The current FCF Margin % is -2.46%. OptimizeRx's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For OptimizeRx (OPRX), the current FCF Margin % is -2.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OptimizeRx (OPRX) Overvalued in 2026?
Based on GuruFocus' analysis, OptimizeRx stock appears to be undervalued.
The current stock price of $4.74 is trading 63.5% below its estimated GF Value™ of $12.99.
GuruFocus considers OptimizeRx to be Significantly Undervalued.
Key valuation signals for OPRX:
FCF Margin %: -2.46%
GF Value™: $12.99 vs. price of $4.74 (63.5% below fair value)
No single metric tells the full story. See the OPRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
54GF Score
Get the complete analysis for OPRX
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPRX has been successfully added to your 
